Back to search
FDAFDA · Food and drugs·Recall number D-0040-2025

Ascorbic Acid Inj. Solution, 25,000mg/50mL (500mg/mL), 50mL single use vial, Rx only, Staska Pharmaceuticals, 742 Evergreen Drive, Bennet, NE 68317

Published November 13, 2024 · Recall initiated: September 30, 2024

Summary

FDA records drug Class I recall D-0040-2025, published November 13, 2024 and initiated September 30, 2024. Recalling firm: Staska Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 4773 vials; Lot: Lot #SP2400058, Exp 12/31/2024. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: Presence of glass particulates.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Staska Pharmaceuticals, Inc.
Distributor
Nationwide in the USA
Lot
Lot #SP2400058, Exp 12/31/2024
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ascorbic Acid Inj. Solution, 25,000mg/50mL (500mg/mL), 50mL single use vial, Rx only, Staska Pharmaceuticals, 742 Evergreen Drive, Bennet, NE 68317 recalled?

Yes. FDA published recall D-0040-2025 on November 13, 2024. Reported hazard: Presence of Particulate Matter: Presence of glass particulates.

What should I do if I have this product?

Voluntary: Firm initiated · Letter